相关实验视频
Updated: May 6, 2026

08:12
Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
13.7K
在心肌细胞中诱导过渡细胞周期以治疗亚急性缺血性心力衰竭
Riham R E Abouleisa1, Abou Bakr M Salama1,2, Qinghui Ou1
1From the Institute of Molecular Cardiology (R.R.E.A., A.B.M.S., Q.O., X.-L.T., M.S., Y.G., Y.N., K.M.K., S.K.H., R.B., T.M.A.M.), University of Louisville, KY.
Circulation
|January 21, 2022
概括
这项研究使用四个细胞周期因子 (4F) 确定了强迫心肌细胞增殖的关键重编程阶段. 在小鼠和猪模型中进行的临床前试验表明,肌肉梗塞后心脏功能和安全性得到改善,为心力衰竭推进4F基因治疗.
科学领域:
- 心血管生物学
- 复原医学
- 基因治疗
背景情况:
- 心肌梗塞 (MI) 后内源性心脏再生有限.
- 之前的研究表明,四种细胞周期因子 (4F) 促进心肌细胞的增殖,并改善小鼠的心脏功能.
- 需要了解4F治疗的机制和临床前疗效.
研究的目的:
- 确定4F诱导的心肌细胞增殖过程中的重编程阶段.
- 在大型动物模型中对缺血性心力衰竭进行4F基因治疗的临床前测试.
主要方法:
- 时间单细胞RNA测序以分析心肌细胞重编程.
- 一种短暂的,心肌细胞特异的晶状病毒载体 (TNNT2-4F多晶体- NIL) 的发展.
- 在老鼠和猪MI模型中注射病毒载体.
主要成果:
- 在15%的心肌细胞中诱导细胞循环重编程,与代谢变化有关.
- 在老鼠和猪中,用TNNT2-4F多聚氨酸治疗显著改善了喷射分数和减少了痕大小.
- 在治疗后4个月内观察到持续的心脏功能改善和不出现心律失常或瘤发生.
结论:
- 获得了强迫心肌细胞增殖的机制见解.
- 一种新的过渡性和心肌细胞特异性病毒结构最大限度地降低了致癌风险.
- 这项研究支持4F基因治疗治疗缺血性心力衰竭的临床可行性.
相关概念视频
The Cardiac Cycle
77.6K
The heart beats rhythmically in a sequence called the cardiac cycle—a rapid coordination of contraction (systole) and relaxation (diastole).
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and...
The Process
Electrical signals—sent from the sinoatrial (SA) node in the right atrial wall to the atrioventricular (AV) node between the right atrium and right ventricle—cause both atria to simultaneously contract. When the signal reaches the AV node, it pauses for approximately a tenth of a second, allowing the atria to contract and...
77.6K
Electrophysiology of Normal Cardiac Rhythm
7.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
7.8K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy V: Interprofessional Care
761
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761

